Spiriva Respimat (tiotropium bromide): Reviews and patient testimonials
Medication indications
Spiriva Respimat 2.5 microgram, inhalation solution
COPD
Tiotropium is indicated as a maintenance bronchodilator treatment to relieve symptoms of patients with chronic obstructive pulmonary disease (COPD).Asthma
Spiriva Respimat is indicated as an add-on maintenance bronchodilator treatment in adult patients with asthma who are currently treated with the maintenance combination of inhaled corticosteroids (≥800 µg budesonide/day or equivalent) and long-acting β2 agonists and who experienced one or more severe exacerbations in the previous year.Route of administration: opinion.traitement.inhalation
Molecule: tiotropium bromide
Patients' opinions on Spiriva Respimat
In brief
General satisfaction level: 9.20/10 Learn more
Treatment's effectiveness: 8.80/10 Learn more
Ease of use: 6.40/10 Learn more
Adherence to prescription: 9.60/10 Learn more
Detected side effects: 2.80/10 Learn more
Improvement in the quality of life: 8.60/10 Learn more
1 = Not at all satisfied
10 = Extremely satisfied
1 = Not at all satisfied
10 = Extremely satisfied
1 = Not at all satisfied
10 = Extremely satisfied
1 = Never
10 = Always
1 = Not at all important
10 = Extremely important
1 = Not at all satisfied
10 = Extremely satisfied
Tips and advice of the community